<html><body><h2>Case: 125782</h2><h3> CDS Time: 1929-06-24</h3>
<patient name=125782>
29.0 year old Asian_or_Pacific-Islander_Non-Hispanic Female
<p><b>Lab & Note Entry Values:</b> <table>
<b><tr><td width="200">Lab</td><td width="200">Value</td><td width="200">Date</td></tr></b>
<tr><td width="200">Age</td><td width="200">29</td><td width="200">1970-1-1</td></tr>
<tr><td width="200">Calcium</td><td width="200">8</td><td width="200">1929-6-24</td></tr>
<tr><td width="200">Alkaline_phosphatase</td><td width="200">138</td><td width="200">1929-6-11</td></tr>
<tr><td width="200">Phosphorus</td><td width="200">5</td><td width="200">1929-5-20</td></tr>
<tr><td width="200">LDL_Cholesterol</td><td width="200">79</td><td width="200">1928-6-11</td></tr>
<tr><td width="200">Chloride</td><td width="200">94.0</td><td width="200">1929-6-24</td></tr>
<tr><td width="200">HDL_Cholesterol</td><td width="200">35</td><td width="200">1928-6-11</td></tr>
<tr><td width="200">Diastolic_BP</td><td width="200">69</td><td width="200">1929-6-24</td></tr>
<tr><td width="200">B 12</td><td width="200">616.0</td><td width="200">1928-9-14</td></tr>
<tr><td width="200">Weight</td><td width="200">157</td><td width="200">1929-6-13</td></tr>
<tr><td width="200">HbA1C</td><td width="200">6</td><td width="200">1929-6-6</td></tr>
<tr><td width="200">Triglycerides</td><td width="200">166</td><td width="200">1928-6-11</td></tr>
<tr><td width="200">Total_Cholesterol</td><td width="200">147</td><td width="200">1928-6-11</td></tr>
<tr><td width="200">SGOT</td><td width="200">13</td><td width="200">1929-6-11</td></tr>
<tr><td width="200">Systolic_BP</td><td width="200">113</td><td width="200">1929-6-24</td></tr>
<tr><td width="200">Total_Bilirubin</td><td width="200">0</td><td width="200">1929-6-11</td></tr>
<tr><td width="200">Height</td><td width="200">66</td><td width="200">1929-6-13</td></tr>
<tr><td width="200">Potassium</td><td width="200">4</td><td width="200">1929-6-24</td></tr>
<tr><td width="200">Cholesterol</td><td width="200">147</td><td width="200">1928-6-11</td></tr>
<tr><td width="200">BUN</td><td width="200">33</td><td width="200">1929-6-24</td></tr>
<tr><td width="200">HCT</td><td width="200">32</td><td width="200">1929-6-18</td></tr>
<tr><td width="200">HGB</td><td width="200">11</td><td width="200">1929-6-18</td></tr>
<tr><td width="200">Sodium</td><td width="200">135</td><td width="200">1929-6-24</td></tr>
<tr><td width="200">Albumen</td><td width="200">4</td><td width="200">1929-6-11</td></tr>
<tr><td width="200">Creatinine</td><td width="200">7.9</td><td width="200">1929-6-24</td></tr>
<tr><td width="200">Glycosylated_Hemoglobin</td><td width="200">6</td><td width="200">1929-6-6</td></tr>
<tr><td width="200">Pulse</td><td width="200">71</td><td width="200">1929-6-24</td></tr>
<tr><td width="200">PLT</td><td width="200">206</td><td width="200">1929-6-18</td></tr>
<tr><td width="200">WBC</td><td width="200">5</td><td width="200">1929-6-18</td></tr>
<tr><td width="200">target_HBA1c</td><td width="200">7.0</td><td width="200">1929-6-15</td></tr>
<tr><td width="200">SGPT</td><td width="200">47</td><td width="200">1929-6-11</td></tr>
<tr><td width="200">Sex</td><td width="200">Female</td><td width="200"></td></tr>
<tr><td width="200">Race</td><td width="200">Asian_or_Pacific-Islander_Non-Hispanic</td><td width="200"></td></tr>
<tr><td width="200">Diabetes with renal manifestations</td><td width="200"></td><td width="200">1929-5-31</td></tr>
<tr><td width="200">Diabetes-Mellitus-Type1</td><td width="200"></td><td width="200">1928-11-26</td></tr>
<tr><td width="200">DM-Type2</td><td width="200"></td><td width="200">1929-6-15</td></tr>
<tr><td width="200">edema</td><td width="200"></td><td width="200">1929-6-15</td></tr>
<tr><td width="200">End-Stage_Renal_Disease</td><td width="200"></td><td width="200">1929-6-15</td></tr>
<tr><td width="200">Atrial_Fibrillation</td><td width="200"></td><td width="200">1928-10-4</td></tr>
<tr><td width="200">Cardiomegaly</td><td width="200"></td><td width="200">1929-5-18</td></tr>
<tr><td width="200">Depression</td><td width="200"></td><td width="200">1928-7-14</td></tr>
<tr><td width="200">CKD</td><td width="200"></td><td width="200">1928-8-28</td></tr>
<tr><td width="200">Hepatitis_B_Surface_Antigen</td><td width="200">Negative</td><td width="200">1926-12-19</td></tr>
<tr><td width="200">fluid retention</td><td width="200"></td><td width="200">1928-11-28</td></tr>
<tr><td width="200">Heart_Failure</td><td width="200"></td><td width="200">1928-7-7</td></tr>
<tr><td width="200">Hypercalcemia</td><td width="200"></td><td width="200">1929-6-7</td></tr>
<tr><td width="200">Hypertension</td><td width="200"></td><td width="200">1929-6-7</td></tr>
<tr><td width="200">nausea</td><td width="200"></td><td width="200">1929-6-5</td></tr>
<tr><td width="200">Nephritis_nephrosis_renal sclerosis</td><td width="200"></td><td width="200">1929-6-13</td></tr>
<tr><td width="200">Occulusion of cerebral arteries</td><td width="200"></td><td width="200">1928-7-10</td></tr>
<tr><td width="200">Renal_Insufficiency</td><td width="200"></td><td width="200">1929-5-24</td></tr>
<tr><td width="200">Renal disease</td><td width="200"></td><td width="200">1929-6-13</td></tr>
<tr><td width="200">Secondary_Hypertension</td><td width="200"></td><td width="200">1928-11-26</td></tr>
<tr><td width="200">Renovascular_Disease</td><td width="200"></td><td width="200">1929-5-31</td></tr>
<tr><td width="200">Volume overload</td><td width="200"></td><td width="200">1928-11-28</td></tr>
</table>
<p><b>Medications:</b> aspirin(325.0) labetalol(1200.0) clonidine(0.0) simvastatin(10.0) lisinopril(40.0) hydralazine(100.0) lovastatin(20.0) furosemide(80.0) Insulin(12.0) 
<p><b>Problems:</b> <table>
<tr><td width="200"><b>Problem Class</b></td><td width="200"><b>First/Last Dates Reported</b></td><td width="200"></td></tr>
<tr><td width="200">Renal_insufficiency_w_creat>=2.1</td>
<td width="200"></td>
<td width="200"> Renal Insufficiency[Creatinine(7.9/1929-6-24)]()</td></tr>
<tr><td width="200">Target_Organ_Damage_Clinical_Cardiovascular_Disease</td>
<td width="200"></td>
<td width="200"> TOD/CCD[presence of heart failure]()</td></tr>
<tr><td width="200">Dyslipidemia Lab criteria</td>
<td width="200"></td>
<td width="200"> Dyslipidemia Lab criteria[HDL_Cholesterol(35.0/1928-6-11)]()</td></tr>
<tr><td width="200">DM (2ary prev)  BP controlled</td>
<td width="200"></td>
<td width="200"> Diabetes (Secondary Prevention)[Treatment_Diastolic_BP(69/null) && Treatment_Systolic_BP(113/null) && presence of diabetes mellitus]()</td></tr>
<tr><td width="200">Heart Failure  (Secondary Prev) BP controlled</td>
<td width="200"></td>
<td width="200"> Heart Failure (Secondary Prevention)[Treatment_Diastolic_BP(69/null) && Treatment_Systolic_BP(113/null) && presence of heart failure]()</td></tr>
<tr><td width="200">Heart Failure (second prev) BP cont</td>
<td width="200"></td>
<td width="200"> Heart Failure (Secondary prevention)[Treatment_Diastolic_BP(69/null) && Treatment_Systolic_BP(113/null) && heart failure present]()</td></tr>
<tr><td width="200">Major Cardiovascular Risk Factor</td>
<td width="200"></td>
<td width="200"> Major Cardiovascular Risk Factor[presence of diabetes mellitus]()</td></tr>
<tr><td width="200">Dyslipidemia Lab or ICD9</td>
<td width="200"></td>
<td width="200"> Dyslipidemia Lab or ICD9[presence of dyslipidemia lab criteria]()</td></tr>
<tr><td width="200">CKD by eGFR or ICD9 codes</td>
<td width="200"></td>
<td width="200"> CKD[presence of CKD (icd9 codes)]()</td></tr>
<tr><td width="200">On meds & Presence of strong contraindication to HCTZ or using bad drug partner</td>
<td width="200"></td>
<td width="200"> Hypertension[taking furosemide && Antihypertensive_Agents]()</td></tr>
<tr><td width="200">active prescription for furosemide</td>
<td width="200"></td>
<td width="200"> active prescription for furosemide[taking furosemide]()</td></tr>
<tr><td width="200">on >= 1 med</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">taking >= 2 anti hypertensive meds</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">On 1 drug and there exists contraindicated drug or a compelling drug not given</td>
<td width="200"></td>
<td width="200"> On 1 drug and there exists contraindicated drug or a compelling drug not given[there exists a compellingly indicated drug that is not already given]()</td></tr>
<tr><td width="200">drug intolerance ACE/ARB OR hypotension OR renal insufficiency</td>
<td width="200"></td>
<td width="200"> drug intolerance ACE/ARB OR hypotension OR renal insufficiency[presence of renal insufficiency ICD9]()</td></tr>
<tr><td width="200">Absence of Stage D HF</td>
<td width="200"></td>
<td width="200"> Absence of Stage D HF[Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF)]()</td></tr>
<tr><td width="200">Female and most recent creatinine  >2</td>
<td width="200"></td>
<td width="200"> Female and most recent creatinine  >2[Sex(Female) && Creatinine(7.9/1929-6-24)]()</td></tr>
<tr><td width="200">Renal-Urinary_Diseases</td>
<td width="200">1929-06-13</td>
<td width="200"> Nephritis_nephrosis_renal sclerosis()</td></tr>
<tr> <td width="200"></td>
<td width="200">1929-05-31</td>
<td width="200"> Renovascular_Disease()</td></tr>
<tr> <td width="200"></td>
<td width="200">1928-08-28</td>
<td width="200"> CKD()</td></tr>
<tr> <td width="200"></td>
<td width="200">1929-05-24</td>
<td width="200"> Renal_Insufficiency()</td></tr>
<tr> <td width="200"></td>
<td width="200">1929-06-13</td>
<td width="200"> Renal disease()</td></tr>
<tr><td width="200">Hepatobiliary_Diseases</td>
<td width="200"></td>
<td width="200"> Active Liver Disease[SGPT(47.0/1929-6-11)]()</td></tr>
<tr><td width="200">CCS-7.4</td>
<td width="200">1928-07-10</td>
<td width="200"> Occulusion of cerebral arteries()</td></tr>
<tr><td width="200">CCS-7.2</td>
<td width="200">1928-07-07</td>
<td width="200"> Heart_Failure()</td></tr>
<tr> <td width="200"></td>
<td width="200">1929-05-18</td>
<td width="200"> Cardiomegaly()</td></tr>
<tr> <td width="200"></td>
<td width="200">1928-10-04</td>
<td width="200"> Atrial_Fibrillation()</td></tr>
<tr><td width="200">Hypertension_Inclusive</td>
<td width="200">1929-06-07</td>
<td width="200"> Hypertension()</td></tr>
<tr><td width="200">Secondary_Hypertension</td>
<td width="200">1928-11-26</td>
<td width="200"> Secondary_Hypertension()</td></tr>
<tr><td width="200">Psychiatric_Diseases</td>
<td width="200">1928-07-14</td>
<td width="200"> Depression()</td></tr>
<tr><td width="200">Metabolic&Nutritional_Diseases</td>
<td width="200">1929-06-07</td>
<td width="200"> Hypercalcemia()</td></tr>
<tr><td width="200">Endocrine_Diseases</td>
<td width="200">1928-11-26</td>
<td width="200"> Diabetes-Mellitus-Type1()</td></tr>
<tr> <td width="200"></td>
<td width="200">1929-06-15</td>
<td width="200"> DM-Type2()</td></tr>
<tr> <td width="200"></td>
<td width="200">1929-05-31</td>
<td width="200"> Diabetes with renal manifestations()</td></tr>
<tr><td width="200"> <b>Others</b></td>
<td width="200">1928-11-28</td>
<td width="200"> fluid retention()
<tr> <td width="200"></td>
<td width="200">1926-12-19</td>
<td width="200"> Hepatitis_B_Surface_Antigen()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Race()
<tr> <td width="200"></td>
<td width="200">1928-11-28</td>
<td width="200"> Volume overload()
<tr> <td width="200"></td>
<td width="200">1929-06-15</td>
<td width="200"> End-Stage_Renal_Disease()
<tr> <td width="200"></td>
<td width="200">1929-06-05</td>
<td width="200"> nausea()
<tr> <td width="200"></td>
<td width="200">1929-06-15</td>
<td width="200"> edema()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Sex()
</table><p>
</patient>
<h1 align="center">ATHENA Heart Failure Guideline</h1>
<b>Patient classification:</b> <ul>
<li>ATHENA Heart Failure Guideline: true[because <i> Eligibility criteria </i> evaluate to <b>true</b><i>(Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF))</i>]
</ul>
<b>Scenario choice:</b> Stage C HF
<p>
<b>Goal:</b> LDL< 100 mg/dL(CHD Risk Equivalent)
<p><b>Reached goal?</b> achieved(LDL_Cholesterol(79.0/1928-6-11))
<p>
<b>Goal:</b> SBP < 140 and DBP < 80(presence of diabetes mellitus)
<p><b>Reached goal?</b> achieved(Treatment_Diastolic_BP(69/null) && Treatment_Systolic_BP(113/null))
<p><b>Messages by Types</b>
<ul>
<li><b>Class II a</b>
<ul>
<li>It is reasonable to treat patients with atrial fibrillation and HF with a strategy to maintain sinus rhythm or with a strategy to control ventricular rate alone. (Level of Evidence: A)
<li>Maximal exercise testing with or without measurement of respiratory gas exchange is reasonable to facilitate prescription of an appropriate exercise program for patients presenting with HF. (Level of Evidence: C)
</ul>
<li><b>Class I</b>
<ul>
<li>Exercise training is beneficial as an adjunctive approach to improve clinical status in ambulatory patients with current or prior symptoms of HF and reduced LVEF. (Level of Evidence: B)
</ul>
<li><b>Class III</b>
<ul>
<li>Use of nutritional supplements to treat structural heart disease or to prevent the development of symptoms of HF is NOT recommended.
</ul>
</ul>
<p><b>Action Choices</b>
<ul>
<li><b>Stage C HF</b><br>
<ul>
</ul>
<li><b> </b><br>
<ul>
<li><b>General Recommendations <font color=FF0000>preferred</font></b>(strict rule-in condition<i> HF ICD9 code OR( signs and structural abnormality)</i> evaluate to <b> true</b> because <i>Presence of HF</i>)])
Exercise training is beneficial as an adjunctive approach to improve clinical status in ambulatory patients with current or prior symptoms of HF and reduced LVEF. (Level of Evidence: B)
It is reasonable to treat patients with atrial fibrillation and HF with a strategy to maintain sinus rhythm or with a strategy to control ventricular rate alone. (Level of Evidence: A)
Maximal exercise testing with or without measurement of respiratory gas exchange is reasonable to facilitate prescription of an appropriate exercise program for patients presenting with HF. (Level of Evidence: C)

<li><b>Referrals <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])
Class I
<li><b>Stage B HF action <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])

Use of nutritional supplements to treat structural heart disease or to prevent the development of symptoms of HF is NOT recommended.
</ul>
</ul>
<b>Considerations for adding drug: </b><ul><li>hydralazine and nitrates<ul><li>preference: neutral<li>No comment</ul><li>Beta blocker for stage C heart failure(Bisoprolol, Sustained release metoprolol succinate, Carvedilol)<ul><li>preference: neutral<li>No comment</ul><li>Beta blocker Stage C with MI(Carvedilol)<ul><li>preference: neutral<li>No comment</ul><li>aldosterone antagonist<ul><li>Contraindications:  Female and most recent creatinine  >2(Female and most recent creatinine  >2[Sex(Female) && Creatinine(7.9/1929-6-24)]) <li>preference: ruled out</ul></ul><b>Considerations for adding drug: </b><ul><li>ARB<ul><li>preference: neutral<li>No comment</ul><li>digoxin<ul><li>preference: neutral<li>No comment</ul><li>Beta blocker stage B post MI(atenolol)<ul><li>preference: neutral<li>No comment</ul><li>Ace_Inhibitor(Enalapril)<ul><li>Already being used<li>preference: ruled out</ul><li>NDHP CCB<ul><li>Contraindications:  Heart_Failure(Cardiomegaly, Heart_Failure) <li>preference: ruled out</ul><li>Beta Blocker Stage B no MI<ul><li>Already being used<li>preference: ruled out</ul></ul></body></html>